# D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab

> **NCT07684066** · — · NOT_YET_RECRUITING · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 116 (estimated)

## Conditions studied

- Cutaneous Squamous Cell Carcinoma (CSCC)
- Advanced Cutaneous Squamous Cell Carcinoma
- Metastatic Cutaneous Squamous Cell Carcinoma

## Interventions

- **OTHER:** Pretreatment D-dimer status

## Key facts

- **NCT ID:** NCT07684066
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2028-07-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07684066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07684066, "D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07684066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*